Search research articles
Contact Us
Filters
Showing results (221-230 of 400) with videos related to
Page
of 40
Sort By:
Journal of Clinical Medicine
|
May 14, 2020
Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy-Do Different Software Solutions Deliver Comparable Results?
Philipp E Hartrampf, Marieke Heinrich, Anna Katharina Seitz, et al.
Frontiers in Oncology
|
September 3, 2019
CXCR4-Directed Imaging in Solid Tumors
Rudolf A Werner, Stefan Kircher, Takahiro Higuchi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 1, 2022
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA I&T during long-term follow-up
Philipp E Hartrampf, Anna Katharina Seitz, Franz-Xaver Weinzierl, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 25, 2019
Detection of cardiac amyloidosis with <sup>18</sup>F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy
Malte Kircher, Sandra Ihne, Joachim Brumberg, et al.
Scientific Reports
|
May 20, 2025
Value of PET radiomic features for diagnosis and reccurence prediction of newly diagnosed oral squamous cell carcinoma
Elisabeth Pfaehler, Andreas Schindele, Alexander Dierks, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 15, 1991
Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes
D K Grandy, Y A Zhang, C Bouvier, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 16, 2026
CXCR4-targeted PET/CT in early systemic sclerosis-associated interstitial lung disease: a prospective proof-of-concept study of in vivo inflammatory activity
Michael Gernert, Marc Schmalzing, Hannah Labinsky, et al.
Genes, Brain, and Behavior
|
July 29, 2003
Multiple cross mapping (MCM) markedly improves the localization of a QTL for ethanol-induced activation
R Hitzemann, B Malmanger, S Cooper, et al.
Clinical Nuclear Medicine
|
April 19, 2022
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy
Sebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Clinical Nuclear Medicine
|
May 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Page
of 40
Search research articles
Search
Showing results (221-230 of 400) with videos related to
Sort By:
Page
of 40
Journal of Clinical Medicine
|
May 14, 2020
Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy-Do Different Software Solutions Deliver Comparable Results?
Philipp E Hartrampf, Marieke Heinrich, Anna Katharina Seitz, et al.
Frontiers in Oncology
|
September 3, 2019
CXCR4-Directed Imaging in Solid Tumors
Rudolf A Werner, Stefan Kircher, Takahiro Higuchi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 1, 2022
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA I&T during long-term follow-up
Philipp E Hartrampf, Anna Katharina Seitz, Franz-Xaver Weinzierl, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 25, 2019
Detection of cardiac amyloidosis with <sup>18</sup>F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy
Malte Kircher, Sandra Ihne, Joachim Brumberg, et al.
Scientific Reports
|
May 20, 2025
Value of PET radiomic features for diagnosis and reccurence prediction of newly diagnosed oral squamous cell carcinoma
Elisabeth Pfaehler, Andreas Schindele, Alexander Dierks, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 15, 1991
Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes
D K Grandy, Y A Zhang, C Bouvier, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 16, 2026
CXCR4-targeted PET/CT in early systemic sclerosis-associated interstitial lung disease: a prospective proof-of-concept study of in vivo inflammatory activity
Michael Gernert, Marc Schmalzing, Hannah Labinsky, et al.
Genes, Brain, and Behavior
|
July 29, 2003
Multiple cross mapping (MCM) markedly improves the localization of a QTL for ethanol-induced activation
R Hitzemann, B Malmanger, S Cooper, et al.
Clinical Nuclear Medicine
|
April 19, 2022
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy
Sebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Clinical Nuclear Medicine
|
May 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Page
of 40